BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29567821)

  • 1. Costs of Cancer Care Across the Disease Continuum.
    Kaye DR; Min HS; Herrel LA; Dupree JM; Ellimoottil C; Miller DC
    Oncologist; 2018 Jul; 23(7):798-805. PubMed ID: 29567821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. System-Level Health-Care Integration and the Costs of Cancer Care Across the Disease Continuum.
    Kaye DR; Min HS; Norton EC; Ye Z; Li J; Dupree JM; Ellimoottil C; Miller DC; Herrel LA
    J Oncol Pract; 2018 Mar; 14(3):e149-e157. PubMed ID: 29443647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis.
    Riley GF; Potosky AL; Lubitz JD; Kessler LG
    Med Care; 1995 Aug; 33(8):828-41. PubMed ID: 7637404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of trends in the cost of initial cancer treatment.
    Warren JL; Yabroff KR; Meekins A; Topor M; Lamont EB; Brown ML
    J Natl Cancer Inst; 2008 Jun; 100(12):888-97. PubMed ID: 18544740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of care for elderly cancer patients in the United States.
    Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
    J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer.
    Brown ML; Riley GF; Potosky AL; Etzioni RD
    Med Care; 1999 Dec; 37(12):1249-59. PubMed ID: 10599606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient time costs associated with cancer care.
    Yabroff KR; Davis WW; Lamont EB; Fahey A; Topor M; Brown ML; Warren JL
    J Natl Cancer Inst; 2007 Jan; 99(1):14-23. PubMed ID: 17202109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Affecting Racial Disparities in End-of-Life Care Costs Among Lung Cancer Patients: A SEER-Medicare-based Study.
    Karanth S; Rajan SS; Revere FL; Sharma G
    Am J Clin Oncol; 2019 Feb; 42(2):143-153. PubMed ID: 30300168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The end of life costs for Medicare patients with advanced ovarian cancer.
    Urban RR; He H; Alfonso R; Hardesty MM; Goff BA
    Gynecol Oncol; 2018 Feb; 148(2):336-341. PubMed ID: 29208368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in Physician-Specific Episode Payments for Major Cancer Surgery and Implications for the Merit-Based Incentive Program.
    Kaye DR; Dunn RL; Li J; Herrel LA; Dupree JM; Miller DC; Ellimoottil C
    J Surg Res; 2019 Apr; 236():30-36. PubMed ID: 30694769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase-Specific and Lifetime Costs of Multiple Myeloma Among Older Adults in the US.
    Bhattacharya K; Bentley JP; Ramachandran S; Chang Y; Banahan BF; Shah R; Bhakta N; Yang Y
    JAMA Netw Open; 2021 Jul; 4(7):e2116357. PubMed ID: 34241627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Projections of the cost of cancer care in the United States: 2010-2020.
    Mariotto AB; Yabroff KR; Shao Y; Feuer EJ; Brown ML
    J Natl Cancer Inst; 2011 Jan; 103(2):117-28. PubMed ID: 21228314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
    Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003.
    Cipriano LE; Romanus D; Earle CC; Neville BA; Halpern EF; Gazelle GS; McMahon PM
    Value Health; 2011 Jan; 14(1):41-52. PubMed ID: 21211485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences among the elderly in the treatment costs of colorectal cancer: how important is race?
    Wright GE; Barlow WE; Green P; Baldwin LM; Taplin SH
    Med Care; 2007 May; 45(5):420-30. PubMed ID: 17446828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the Medicare hospice benefit and health care utilization and costs for patients with poor-prognosis cancer.
    Obermeyer Z; Makar M; Abujaber S; Dominici F; Block S; Cutler DM
    JAMA; 2014 Nov; 312(18):1888-96. PubMed ID: 25387186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy Use, End-of-Life Care, and Costs of Care Among Patients Diagnosed With Stage IV Pancreatic Cancer.
    Bao Y; Maciejewski RC; Garrido MM; Shah MA; Maciejewski PK; Prigerson HG
    J Pain Symptom Manage; 2018 Apr; 55(4):1113-1121.e3. PubMed ID: 29241809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rural-Urban Differences in Costs of End-of-Life Care for Elderly Cancer Patients in the United States.
    Wang H; Qiu F; Boilesen E; Nayar P; Lander L; Watkins K; Watanabe-Galloway S
    J Rural Health; 2016 Sep; 32(4):353-362. PubMed ID: 26586101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
    Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
    Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The burden of hepatitis C to the United States Medicare system in 2009: Descriptive and economic characteristics.
    Rein DB; Borton J; Liffmann DK; Wittenborn JS
    Hepatology; 2016 Apr; 63(4):1135-44. PubMed ID: 26707033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.